Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
Gui B, Autorino R, Miccò M, Nardangeli A, Pesce A, Lenkowicz J, Cusumano D, Russo L, Persiani S, Boldrini L, Dinapoli N, Macchia G, Sallustio G, Gambacorta MA, Ferrandina G, Manfredi R, Valentini V, Scambia G. Gui B, et al. Among authors: nardangeli a. Diagnostics (Basel). 2021 Mar 31;11(4):631. doi: 10.3390/diagnostics11040631. Diagnostics (Basel). 2021. PMID: 33807494 Free PMC article.
EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis.
Autorino R, Tagliaferri L, Campitelli M, Smaniotto D, Nardangeli A, Mattiucci GC, Macchia G, Gui B, Miccò M, Mascilini F, Ferrandina G, Kovacs G, Valentini V, Gambacorta MA. Autorino R, et al. Among authors: nardangeli a. J Contemp Brachytherapy. 2018 Aug;10(4):315-320. doi: 10.5114/jcb.2018.77953. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237815 Free PMC article.
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC, Boldrini L, Nardangeli A, D'Aviero A, Buwenge M, Cellini F, Deodato F, Dinapoli N, Frascino V, Macchia G, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: nardangeli a. J Cancer Res Clin Oncol. 2021 Mar;147(3):661-667. doi: 10.1007/s00432-020-03411-7. Epub 2020 Oct 1. J Cancer Res Clin Oncol. 2021. PMID: 33001271
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC, Boldrini L, Nardangeli A, D'Aviero A, Buwenge M, Cellini F, Deodato F, Dinapoli N, Frascino V, Macchia G, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: nardangeli a. J Cancer Res Clin Oncol. 2021 Mar;147(3):669. doi: 10.1007/s00432-020-03439-9. J Cancer Res Clin Oncol. 2021. PMID: 33165642 No abstract available.
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates.
Lancellotta V, Macchia G, Dinapoli N, Autorino R, Campitelli M, Nardangeli A, Salvati A, Fionda B, Casà C, Cornacchione P, Rovirosa A, Kovács G, Morganti AG, Ferrandina MG, Gambacorta MA, Tagliaferri L. Lancellotta V, et al. Among authors: nardangeli a. Radiol Med. 2022 Mar;127(3):341-348. doi: 10.1007/s11547-022-01455-y. Epub 2022 Jan 29. Radiol Med. 2022. PMID: 35092552 Free PMC article.
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G, Nardangeli A, Laliscia C, Fodor A, Draghini L, Gentile PC, D'Agostino GR, Balcet V, Bonome P, Ferioli M, Autorino R, Vicenzi L, Raguso A, Borghesi S, Ippolito E, Di Cataldo V, Cilla S, Perrucci E, Campitelli M, Gambacorta MA, Deodato F, Scambia G, Ferrandina G. Macchia G, et al. Among authors: nardangeli a. Int J Gynecol Cancer. 2022 Jun 6;32(6):732-739. doi: 10.1136/ijgc-2021-003237. Int J Gynecol Cancer. 2022. PMID: 35193941
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R, Gui B, Panza G, Boldrini L, Cusumano D, Russo L, Nardangeli A, Persiani S, Campitelli M, Ferrandina G, Macchia G, Valentini V, Gambacorta MA, Manfredi R. Autorino R, et al. Among authors: nardangeli a. Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24. Radiol Med. 2022. PMID: 35325372 Free PMC article. Review.
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
Cusumano D, Russo L, Gui B, Autorino R, Boldrini L, D'Erme L, Persiani S, Catucci F, Broggi S, Panza G, Nardangeli A, Campitelli M, Ferrandina G, Macchia G, Fiorino C, Valentini V, Scambia G, Manfredi R, Gambacorta MA. Cusumano D, et al. Among authors: nardangeli a. Radiother Oncol. 2022 Sep;174:30-36. doi: 10.1016/j.radonc.2022.07.001. Epub 2022 Jul 8. Radiother Oncol. 2022. PMID: 35811004
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology.
Marconi E, Beghella Bartoli F, Meldolesi E, Mariani S, Panza G, Nardangeli A, Dinapoli L, Lees TC, Guido A, Mastronuzzi A, Ruggiero A, Gambacorta MA, Valentini V, Balducci M, Chieffo DPR, Chiesa S. Marconi E, et al. Among authors: nardangeli a. Health Qual Life Outcomes. 2023 Jul 12;21(1):72. doi: 10.1186/s12955-023-02149-3. Health Qual Life Outcomes. 2023. PMID: 37438740 Free PMC article.
16 results